HITMSIR phase Ib trial of intraarterial chimeric antigen receptor Tcell therapy and selective internal radiation therapy for CEA liver metastases

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases

13:39 EDT 3 Jun 2019 | Nature Publishing

More From BioPortfolio on "HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA+ liver metastases"